TransAxon Overview
- Year Founded
-
2021
- Status
-
Out of Business
- Employees
-
2
- Latest Deal Type
-
Out of Business
TransAxon General Information
Description
Developer of a brain-computer interface platform intended to link physiological psychology and artificial intelligence to repair and improve brains. The company's platform aims at developing function and memory-enhancing Autogenous Induced Brain-Computer interfaces (AI-BCI) that don't injure the brain and require fewer therapeutic procedures, enabling patients to get therapeutic implants initially for vision and speech.
Contact Information
Website
www.transaxon.bioCorporate Office
- 40 Kenwyn Street
- Future House, Parnell
- Auckland, 1052
- New Zealand
Corporate Office
- 40 Kenwyn Street
- Future House, Parnell
- Auckland, 1052
- New Zealand
TransAxon Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Out of Business | 20-Dec-2025 | Completed | Out of Business | |||
| 1. Early Stage VC | 01-Jan-2023 | Completed | Generating Revenue |
TransAxon Signals
TransAxon FAQs
-
When was TransAxon founded?
TransAxon was founded in 2021.
-
Where is TransAxon headquartered?
TransAxon is headquartered in Auckland, New Zealand.
-
What is the size of TransAxon?
TransAxon has 2 total employees.
-
What industry is TransAxon in?
TransAxon’s primary industry is Therapeutic Devices.
-
Is TransAxon a private or public company?
TransAxon is a Private company.
-
What is TransAxon’s current revenue?
The current revenue for TransAxon is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process